The formulation containing hyaluronate and tobramycin was more effective than hyaluronate alone in improving the status of the nasal mucosa , in reducing the mucopurulent secretion at the level of the osteomeatal complex and in improving ENT symptoms ( hyposmia/anosmia and headache/facial pain ) .